Axsome Therapeutics, Inc. (AXSM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 611.21M | 588.99M | 565.34M | 536.62M | 494.63M | 485.06M | 479.11M | 463.03M | 460.49M | 504.26M | 511.76M | 519.69M |
| Cash & Short-Term Investments | 305.11M | 322.93M | 325.27M | 303.02M | 300.91M | 315.35M | 327.34M | 315.66M | 331.44M | 386.19M | 416.56M | 437.11M |
| Cash Only | 305.11M | 322.93M | 325.27M | 303.02M | 300.91M | 315.35M | 327.34M | 315.66M | 331.44M | 386.19M | 416.56M | 437.11M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 251.06M | 224.46M | 196.51M | 198.82M | 161.4M | 142M | 124.1M | 120.34M | 101.43M | 94.82M | 78.42M | 67.41M |
| Days Sales Outstanding | 111.92 | 98.8 | 106.35 | 109.24 | 112.4 | 103.06 | 107.33 | 115.77 | 119.06 | 111.41 | 116.07 | 109.32 |
| Inventory | 31.52M | 27.94M | 23.77M | 18.44M | 16.32M | 15.73M | 14.27M | 15.22M | 15.58M | 15.13M | 9.98M | 9.25M |
| Days Inventory Outstanding | 181.69 | 192.94 | 163.02 | 117.61 | 147.34 | 131.24 | 160.76 | 174 | 221.96 | 156.62 | 135.47 | 170.09 |
| Other Current Assets | 23.52M | 13.65M | 19.79M | 16.34M | 16.01M | 11.98M | 13.41M | 11.81M | 12.03M | 8.12M | 6.8M | 5.91M |
| Total Non-Current Assets | 102.4M | 100.82M | 103.91M | 103.17M | 102.04M | 83.43M | 82.34M | 85.2M | 85.24M | 83.97M | 89.09M | 91.95M |
| Property, Plant & Equipment | 20.01M | 20.86M | 26.65M | 23.14M | 24.07M | 5.97M | 5.73M | 6.79M | 9.61M | 7.62M | 8.04M | 8.15M |
| Fixed Asset Turnover | 9.36x | 8.25x | 6.87x | 6.36x | 8.09x | 20.31x | 16.73x | 10.63x | 8.71x | 9.14x | 7.14x | 10.43x |
| Goodwill | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M | 12.04M |
| Intangible Assets | 38.95M | 40.52M | 42.13M | 43.73M | 45.32M | 46.89M | 48.5M | 50.11M | 51.7M | 53.29M | 54.89M | 56.5M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31.4M | 27.4M | 23.09M | 24.25M | 20.61M | 18.53M | 16.07M | 16.25M | 11.89M | 11.03M | 14.12M | 15.26M |
| Total Assets | 713.61M | 689.8M | 669.25M | 639.78M | 596.67M | 568.5M | 561.46M | 548.23M | 545.73M | 588.24M | 600.86M | 611.64M |
| Asset Turnover | 0.27x | 0.29x | 0.26x | 0.24x | 0.21x | 0.21x | 0.19x | 0.16x | 0.13x | 0.12x | 0.10x | 0.09x |
| Asset Growth % | 19.6% | 21.34% | 19.2% | 16.7% | 9.33% | -3.36% | -6.56% | -10.37% | 40.23% | 77.46% | 77.27% | 238.75% |
| Total Current Liabilities | 439.21M | 378.84M | 360.29M | 342.1M | 243.91M | 230.1M | 196.19M | 186.57M | 144.05M | 138.85M | 114.66M | 114.97M |
| Accounts Payable | 106.7M | 65.54M | 54.23M | 91.63M | 85.66M | 72M | 64.25M | 61.34M | 53.79M | 40.68M | 29.1M | 42.96M |
| Days Payables Outstanding | 526.37 | 446.84 | 563.24 | 599.83 | 724.74 | 596.11 | 684.75 | 650.34 | 682.61 | 435.04 | 507.44 | 778.89 |
| Short-Term Debt | 70.63M | 72.98M | 73.23M | 70M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 492K | 0 | 0 | 65.32M |
| Other Current Liabilities | 261.88M | 203.28M | 205.03M | 30.36M | 28.2M | 36.51M | 128.53M | 7.04M | 71.86M | 26.86M | 6.67M | -3.6M |
| Current Ratio | 1.39x | 1.55x | 1.57x | 1.57x | 2.03x | 2.11x | 2.44x | 2.48x | 3.20x | 3.63x | 4.46x | 4.52x |
| Quick Ratio | 1.32x | 1.48x | 1.50x | 1.51x | 1.96x | 2.04x | 2.37x | 2.40x | 3.09x | 3.52x | 4.38x | 4.44x |
| Cash Conversion Cycle | -232.76 | -155.1 | -293.87 | -372.99 | -465 | -361.81 | -416.67 | -360.58 | -341.59 | -167.02 | -255.9 | -499.48 |
| Total Non-Current Liabilities | 219.81M | 222.67M | 235.23M | 224.61M | 299.55M | 281.38M | 272.37M | 258.8M | 257.64M | 258.4M | 216.69M | 217.86M |
| Long-Term Debt | 146.08M | 140.93M | 117.64M | 117.54M | 181.38M | 180.71M | 180M | 179.33M | 178.69M | 178.07M | 177.45M | 176.82M |
| Capital Lease Obligations | 0 | 27.39M | 27.72M | 27.42M | 27.59M | 8.99M | 9.39M | 9.85M | 8.96M | 7.04M | 7.69M | 7.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 73.73M | 54.36M | 89.87M | 79.66M | 90.59M | 91.68M | 82.98M | 69.62M | 70M | 73.3M | 31.55M | 33.5M |
| Total Liabilities | 659.02M | 601.51M | 595.52M | 566.71M | 543.47M | 511.48M | 468.56M | 445.37M | 401.69M | 397.26M | 331.35M | 332.83M |
| Total Debt | 216.71M | 241.29M | 218.6M | 217.31M | 211.23M | 192.96M | 192.3M | 191.8M | 189.43M | 186.37M | 185.57M | 184.71M |
| Net Debt | -88.4M | -81.64M | -106.68M | -85.71M | -89.68M | -122.4M | -135.04M | -123.86M | -142.01M | -199.82M | -230.99M | -252.4M |
| Debt / Equity | 3.97x | 2.73x | 2.96x | 2.97x | 3.97x | 3.38x | 2.07x | 1.86x | 1.32x | 0.98x | 0.69x | 0.66x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -53.47x | -23.00x | -41.17x | -24.44x | -23.44x | -32.86x | -31.66x | -60.08x | -62.18x | -139.99x | -82.06x | -23.83x |
| Total Equity | 54.59M | 88.3M | 73.73M | 73.08M | 53.2M | 57.02M | 92.9M | 102.85M | 144.04M | 190.98M | 269.51M | 278.8M |
| Equity Growth % | 2.6% | 54.86% | -20.64% | -28.95% | -63.06% | -70.15% | -65.53% | -63.11% | 28.82% | 74.32% | 71.27% | 1734.3% |
| Book Value per Share | 1.07 | 1.74 | 1.47 | 1.48 | 1.09 | 1.17 | 1.93 | 2.16 | 3.04 | 4.04 | 5.72 | 6.38 |
| Total Shareholders' Equity | 54.59M | 88.3M | 73.73M | 73.08M | 53.2M | 57.02M | 92.9M | 102.85M | 144.04M | 190.98M | 269.51M | 278.8M |
| Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | -1.37B | -1.31B | -1.28B | -1.23B | -1.18B | -1.12B | -1.05B | -983.27M | -903.93M | -835.57M | -736.92M | -674.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |